CD8A and neoplasm: Among these subsets, cDC1 plays a pivotal role by cross-presenting exogenous antigens on MHC-I molecules, resulting in the activation of CD8+ cytotoxic T lymphocytes (CTLs) and subsequent tumor cell killing (26–28).